FDA Authorizes Novavax’s Updated COVID-19 Vaccine for New Variant Protection
In a significant move to bolster public health amid ongoing COVID-19 challenges, the U.S. Food and Drug Administration (FDA) has granted emergency use authorization for Novavax’s updated COVID-19 vaccine. This decision, announced on August 31, 2024, is aimed at enhancing protection against the latest variants of the virus, particularly as new strains continue to emerge […]